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Neuroendocrine factors play an important role in 
the pathogenesis o f chronic heart failure. Despite 
num erous clinical and experimental studies, the 
role o f the hypothalam ic-pituitary-adrenal axis 
and glucocorticoid horm ones is not fully char­
acterised. Here w e present a study of plasma 
cortisol concentration in 74 chronic heart failure 
patients, divided into four groups based on N YH A  
functional classes I—IV. and in 17 control subjects. 
In parallel, we performed m orphological analy­
sis o f the hypothalam ic-pituitary-adrenal axis 
com ponents from 8  male patients w ho  had died 
from  chronic heart failure, and 9 male controls, 
In our study we applied im m unohistochem ical 
method and quantitative analysis to investigate 
an expression o f hypothalam ic neurohorm ones 
(corticotropin-releasing hormone, vasopressin) 
and adrenocorticotropin horm one in the pitui­
tary, as well as performed general histological 
exam ination of the adrenal cortex. Measurem ent
Introduction
Chronic heart failure (CHF) is a w idely d istri­
buted disorder, expected to become even more 
prevalent in the near future because o f the aging 
o f  the population [ 1). According to the neurohor- 
monal hypothesis |2], CHF is considered now  as a 
highly com plex clinical syndrome, and its m ani­
festation and progress are strongly dependent on 
the activation o f horm ones and cytokines (|3| 
and references cited therein). Various neuroen­
docrine factors, such as norepinephrine, angio­
tensin II. rennin. and endothelin are strongly 
activated in CHF, and a long w ith mechanical sig­
nals they cause an increase in myocyte size and 
hypertrophy o f the heart (|4] and references cited 
therein). Vasopressin (VP) w as also considered as 
an important neuroendocrine pathogenetic fac­
tor o f CHF V P  is synthesized m ainly in magnocel-
o f m orn ing  cortisol concentration in plasma of 
chronic heart failure patients revealed neither 
difference compared to controls nor w ith the 
severity o f the disease. Despite this, a two-fold 
increase in the density o f corticotropin-releasing 
horm one-im m unoreactive neurons as well as a 
two-fold increase in the num ber of corticotro­
pin-releasing horm one neurons co-expressing 
vasopressin in the hypothalam ic paraventricular 
nucleus were found. In the anterior p ituitary the 
density o f adrenocorticotropin ho rm one-im m u­
noreactive cells w as significantly increased. 
General histological analysis o f  the adrenal cor­
tex revealed a drastic th inn ing o f the zona fas- 
ciculata and dystrophic changes in corticocytes. 
Structural changes, observed in the adrenal cor­
tex. suggest a relative glucocorticoid deficiency, 
which may contribute to corticotropin-releas­
ing horm one and adrenocorticotropin hormone 
upregulation in hypothalam us and pituitary of 
chronic heart failure patients.
lular hypothalam ic nuclei and released into 
peripheral blood circuitry from the posterior 
pituitary lobe. However, VP  is also produced by 
parvocellular neurons in the paraventricular 
nucleus (PVN) (for review, see |5|), where VP  co- 
localizes w ith corticotropin-releasing horm one 
(CRH) and potentiates effects of CRH  on pituitary 
corticotrophs, especially under chronic stress 
situation |6,7).
Despite the fact that the role of several neuroen­
docrine system s has been extensively studied in 
CHF patients, the contribution o f the hypotha- 
lamic-pituitary-adrenal (HPA) axis to the patho­
genesis of CHF is not fully understood. The HPA 
axis is the key biological machinery, which is p ri­
m arily activated in response to stress and regu­
lated in a hierarchical m anner via positive and 
negative feedback m echanism s |8|. W ith  respect
to CHF, the literature on  the activity o f the HPA axis is controver­
sial; measurement o f  cortisol in the plasm a of CHF patients 
revealed either norm al concentrations |9,10|, decreased! I ) ,  12|. 
o r increased levels |13.14|. However, recent comprehensive 
study 115| performed on a total of 300 patients afflicted by CHF 
of New  York Heart Association functional classes III or IV  or 
systolic heart failure showed that all these patients have a nor­
mal range of plasma cortisol levels comparable to those in 
healthy ind iv iduals |16|. Neveitheless. higher plasma cortisol 
(w ith in in a normal range o f cortisol concentrations) had a posi­
tive correlation w ith  higher m ortality risk in CHF patients [151. 
The pituitary function of CHF patients has been exam ined by 
on ly  one group 117|. w h ich  showed elevated adrenocorticotro­
pin horm one (ACTH) levels in the plasma. W h ile  the responses 
o f pituitary to CRH  as well as the basal activity of CRH  neurons 
in the hypothalam ic PVN  have not been studied in CHF patients, 
evidence from animal models of CHF strongly suggested an 
upregulation o f CRH  expression 118 .19|.
The aim  of the present work was the analysis o f  plasm a cortisol 
concentrations in CHF patients com bined w ith  postm ortem  
m orphological exam inations of hypothalami, pituitary, and 
adrenal glands. In the course of this study we found no changes 
in cortisol plasma concentration in CHF patients, even w ith 
severe form |lll, IV  functional classes, according to the New  York 
Heart Association (N Y H A ) criteria), w h ich w as accompanied by 
dystrophic changes in the adrenal cortex. These find ings coin­
cided w ith  a profound increase o f CRH  expression in the hypoth­
a lam us and ACTH expression in the pituitary, suggesting a 
disbalance in feed-back signalling in the HPA ax is o f CHF 
patients.
Measurement of plasma cortisol concentrations 
Seventy-four patien tsofbothgenders(41  males and 33  females), 
rangi ng in age from 32 -8 8  years (64 8  ± 11.5 years) were divided 
into groups based on functional classes (I: 4  patients; II: 19 
patients; III: 23  patients. IV: 28 patients) o f  CHF according to the 
N YH A  criteria. Patients w ith  myocardial infarction w ith in  the 
previous 12 m onths were excluded. The control group  contained 
blood sam ples from 17 ind iv iduals (8 males and 9  females; age 
ranging from 45  to 68  years; mean age 60.8 ± 4.98 years) w ithout 
know n neurological, psychiatric or endocrinological diseases. 
These patients had initial s igns o f CHF, such as slight dyspnoea 
during  physical activity, but did not have other sym ptom s to 
assess any stage o f CHF. Blood sam ples from all patients were 
collected at the same time in the m orn ing  (8 - IO A M ) .  Plasma 
cortisol levels were measured by enzym e im m unoassays (DRG® 
Cortisol ELISA  Kit. DRG International. Inc., Mountainside. NJ. 
USA). W ritten informed consent was obtained from  all patients 
before the study. The study was in agreement w ith  the gu ide­
lines approved by the ethics com mittee of the Russian State 
Medical University (Moscow, Russia).
Postm ortem  m orphological study
y
Tissue codec bon
Brains from patients were obtained according to the Russian law 
at autopsy from  the Regional Medical Expert Bureau of Medical 
Legal Exam ination (Kaliningrad. Russia) and from  an Em ergency
Hospital (Kursk. Russia). Som e sam ples o f adrenal g lands were 
obtained from Department of Pathology (Bureau of Pathological 
Anatomy), Regional Hospital (Belgorod, Russia). The study was 
approved by the Local Ethics Committee o f Friednch-Schiller 
University, Jena. Germ any (Protocol 2387-09/08). Brains from 
eight male patients w h o  had CHF. ranging in age from 3 5 -6 5  
years (53.81 9.3 years), were obtained at autopsy. In all cases 
CHF w as verified clinically and/or by autopsy by several patho­
logical criteria: hypertrophy and lipom atosis of the myocardium 
w ith dilated heart chambers: local hypertrophy, dystrophy, or 
atrophy o f cardiom yocytes w ith  their lysis and subsequent car­
diosclerosis; injuries o f blood capillaries w ith an increase of the 
wall thickness: and activation of fibroblasts. Patients had died 
from  acute heart or respiratory failure (acute cardiovascular 
insufficiency). The control group  contained samples of brains 
from nine male individuals, ranging in age from 3 6 -7 0  years 
(54.6 i  11.8 years), w ithout know n prim ary neurological or p sy­
chiatric conditions and endocrinological pathology w ho  died 
from non-CH F related causes: acute b ia in  stroke (3), diseases of 
the respiratory system  (2). acute surgical pathology (2). asphyxia 
(I), and traumatic injury (1). Postm ortem time was I5 . 8 ± 6 4 h  
in controls and 22 .5 ± l 1.7h in CHF group. Tissue preparation 
w as performed as described |20|. Briefly, hypothalami, pituitary 
and adrenal glands were fixed by im m ersion in 4 %  paraformal­
dehyde in phosphate-buffered saline (PBS. pH 7.4) at room  tem ­
perature for about 2 months. Tissue samples were dehydrated in 
graded ethanol, embedded in paraffin, cut into serial 6 -8 p m  
coronal or horizontal sections and collected on a series o f 10 
SuperFrost® Plus glass slides (Roth. Karlsruhe. Germany).
Consecutive sections o f p ituitaries and hypothalam i containing 
PVN were stained w ith  antibodies against ACTH or CRH  as 
described |20|, Briefly, after deparaffinisation and rehydratioo. 
sections were incubated in phosphate-buffered saline (PBS) con­
taining 10%  methanol and 3%  hydrogen peroxide. After preincu­
bation w ith 0.05%  Triton X  100-PBS containing 5 %  norm al goat 
serum  (PBS-NGS), sections were incubated overnight w ith one 
o f the prim ary rabbit polyclonal antibodies -  anti-CRH  (1:1 000, 
Peninsula Labs Inc.) or anti-ACTH (1:200, Chenucon Interna­
tional. CA. USA) in w ork ing  solution (W S; 1 % NGS, 0.05*. Triton 
on  PBS, pH 7.4). Then sections were washed w ith  PBS and incu ­
bated in W S  w ith biotinylated goat anti-rabbit IgG ( 1:200, Vector 
Elite kit. Vector Laboratories. Inc.. Burlingame, CA, USA). After 
w ash ing w ith PBS, ABC com plex (Vector Laboratories, CA. USA) 
in PBS was applied. The reaction was visualised w ith  diam i- 
nobenzidine (DAB. Sigm a) and H^Oi in PBS. After rinsing w ith 
distilled water, sections were dehydrated in ethanol, cleared in 
xylene and mounted w ith  em bedding m edium  (Entellan. Merck. 
Rahway. NJ, USA). For control incubations we used NGS. diluted 
to 1:1000  in PBS-Triton X  instead of the prim ary antibodies. Sec­
tions of adrenal g lands were stained w ith hem atoxylm -eosin as 
described |20). To evaluate co-localization o f CRH  w ith  V P d o u  
ble fluorescent im m unostain ings were performed Slides were 
preincubated w ith l% T r it o n X  100-PBS containing 10%  NGS and 
then w ith the m ixture o f  the p rim ary antibodies: rabbit polyclo 
nal anti-CRH: Peninsula Labs Inc.. 1:200 and m ouse monoclonal 
PS41 anti-VP, 1:100, provided by Dr. Harold Gainer |21.22|. d is­
solved in 0 .5 % T r ito n X  100-PBS containing 1 % N G S (W S ). Im m u- 
nosignals for CRH  and VP  were visualised by a Cy3-conjugated 
goat anti-rabbit and a FITC-conjugated goat anti-m ouse IgG 
(1 :100 in W S. Dianova.). Sections were mounted w ith antifading
m edium  (Fluorom ount C, Southern Biotechnology Associates, 
Bio/ol, Eching. Germany).
Semiquantitative analysis
Counting of CRH-positive neurons was performed on an Axio- 
skop m icroscope I Zeiss, Oberkochen, G erm any) equipped w ith a 
motorised stage and Neurolucida software-controlled computer 
system (M icroBrightField Europe, Magdeburg. Germany), The 
contours o f the PVN field occupied by CRH-positive neurons 
were outlined m anually w ith  the cursor using a 5 »objective 
(Plan-Neofluar®). All im m unopositive  neurons containing a 
nucleus and clearly d istinguishable from background w ith in  the 
selected aiea were counted using a 20 »objective |23]. Cells were 
labeled by a sym bol and their num bers as well as an outlined 
area were estimated automatically. Finally, cell profile densities 
(num bers o f cell profiles per unit area) o f  CRH-positive cells in 
each subject were calculated based on the total num ber of 
counted neurons in the sam ple and the estimated sample area 
|24|. Additionally, average nearest ne ighbour distances between 
immunolabeled neurons were calculated using Neuroexplorer 
software (M icroBrightField Europe, Magdeburg. Germany). At 
least three hypothalam ic sections from each subject were ana­
lysed.
Counting of double-labeled CRH/VP neurons was performed on 
the digital images o f the im m unostained sections obtained w ith 
a confocal laser scanning m icroscope TCS SP5 (Leica, 20*objec- 
tive, 1 0 2 4 *  1 024  pixels resolution) using the "Im age Tool 2.0” 
software. Stacks of images of 1 pm  thickness were obtained from 
different parts o f the PVN in sections double-stained for CRH 
and VP. Then, the three-dim ensional reconstruction o f the Z- 
series was performed to assess an overlap between CRH and VP  
for confirmation o f co-localized im m unoproducts. The total 
num ber of CRH-positive neurons and the num ber o f CRH neu­
rons im m unopositive for V P  were counted. Then the percentage 
of single and double-labeled CRH-positive cells was calculated. 
All counts were b lindly performed on coded preparations by the 
same investigator.
Counting of ACTH-labeled cells in the anterior lobe of pituitary 
was performed on the digital images of the im m unostained sec­
tions obtained w ith a digital camera "O lym pus D P10” w ith the 
"DP-Soft 3.0" software (2 0 »objective) using the “Image Tool 2.0" 
software (University o f Texas Health Science Center. San Anto­
nio. Texas). The num ber of all im m unopositive cells w ith in  the 
defined area (100pm  *  100pm ) w as estimated and then the cell 
profile density w as calculated. From each subject nine fields 
were analysed in three sections.
Photographical documentation
Im m unohistochem ically stained sections w ith  D AB  visualisation 
o f final products were exam ined w ith  an “O lym pus BX50 " 
microscope. An "O lym pu s D P10 " digital camera w ith “D P  Soft 
3.0” software was used for m icrophotography. Digital images 
were adjusted for contrast and brightness in “Adobe Photoshop" 
(Adobe System s version 8.0.1).
Statistical analysis
T
The differences in blood cortisol concentrations were analysed 
by one-way analysis o f variance (ANOVA) for repeated measures 
using the online program  http://faculty.vassar.edu. Two-tailed 
parametric test (t-test) w as applied to evaluate the m orphologi­
cal data using "M S  Excel-7.0” tool. All results are presented as a 
group  mean values w ith  standard deviation (SD). The accepted 
level of significance was 5%.
Result»
Plasma cortisol concentrations
Measurem ent of total plasma cortisol revealed no significant sex 
differences either in controls (138.38 + 36.65 ng/ml, males and 
148.62 ± 41.79 ng/ml. females) or CH F pat lents ( 130.09 ± 59.52 ng/ 
ml and 132.16+49.38ng/ml, in males and females, respectively: 
values in patients o f different functional classes of CHF were 
pooled). Com parison of cortisol levels between controls and CHF 
patients revealed no significant difference ( 143.8±41.01 ng/ml. 
controls and 131.01 +55.24ng/m l. CHF patients). There were no 
significant changes in cortisol levels between the groups of CHF 
patients divided into four functional classes o f CHF according to 
the N Y H A  classification ( 121.28 ± 21.96 ng/ml, 121.55± 46.05 ng/ 
ml. 122 .43±38 .2ng/ml and 145 .88±70 .72ng/ml. in patients 
w ith I. II. III. and IV  functional class of CHF, respectively).
CRH neurons 
y
In  the PVN of control patients small and m edium  sized 
CRH -positive neurons were located along the third ventricle 
( Fig. 1A). The intensity of CRH -sta ining varied from poor to 
very strong, but w eakly and moderately stained cells prevailed 
( Fig. 1C). In CHF patients, the population of CRH-positive 
neurons in the PVN was m uch larger in com parison w ith  the 
control group  ( Fig. IB). CRH-im m unoreactivity (IR) appeared 
as clear hom ogeneous cytoplasm ic staining pattern. M ost CRH - 
positive perikarya as well as their processes were intensively 
stained ( Fig. 10). Results o f the quantitative analysis indicate 
that the profile density of CRH-positive neurons in the PVN is 
significantly increased in CHF patients (+  70% ; p< 0.05. l-test), as 
show n in Fig. IE . A  nearest ne ighbour distance analysis was 
also performed to obtain insight into the spatial d istribution of 
CRH-labeled neurons. The average nearest neighbour distance 
between CRH-positive cell profiles in PVN w as significantly 
sm aller in CHF patients (-21  %. p<0.05. t-test. Fig. IF). This 
finding correlates well w ith the estimates o f  cell profile density 
( Fig. IE). In order to evaluate co-expression of CRH  and V P  in 
the sam e neurons we performed double immunofluorescent 
staining ( Fig. 2). A s  indicated in the graph ( Fig. 2C), CRH IR 
w as found in 24 .9+2.6%  o f the VP-positive neurons in controls 
( Fig. 2A). In CHF patients, the proportion o f double-labeled 
neurons was increased almost two-fold as compared w ith the 
controls ( Fig. 2B. C).
Anterior pituitary 
*
In cells o f the anterior lobe of p ituitary ACTH-IR  was found as a 
hom ogenous cytoplasm ic staining pattern. The intensity o f the 
IR signal was m uch more pronounced in patients w ith CHF as 
compared w ith the controls (data not shown). Semiquantitative 
analysis revealed a significant increase (+41  %, p < 0 .0 0 1 ) in rela­
tive density of ACTH-positive cells in the anterior lobe of patients 
afflicted w ith  CHF.
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fig. I Inertjscd CRiHmmunofcactlvity in parvocellular neurons of
the PVN In CM» patients A. C  CRM-positive neurons in a 64-year old 
control patient, at small (A) and big (C) magnifkationv B. D; Numerous 
intensively stained CRH-positive newrons in the PVN ol a 65-year old 
patient afflicted with the O il. at small (B) and b4g (D) magnifications. 
Immunohistochemical staining with anti-CRH antibodies, developed 
by DAB. Scale bars« 100 pm (A. B) and SO pm (C, Ol. fc Relative profile 
density of CRH-positive cells is significantly higher in CHf group than 
in controls F: The average nearest neighbour distance between CRH- 
positive cell profiles In PVN Is significantly smaller in CHf patients. Group 
mean values of the parameters are calculated from individual mean 
values. ‘ p<0  0S (ftcst).
Adrenal cortex
In  CHF patients we observed drastic thinning, plethora and dia- 
pedesis of (he zona fasciculata as well as a d iscom plexation of 
the zona glom erulosa ( Fig. 38), as compared w ith  controls 
( Fig. 3A). Detailed exam ination o f the zona fasciculata 
revealed a profound vacuolated dystrophy ( Fig. 3C), pyknosis 
( Fig. 3C. D ) and delipidation of corticocytes in the presence of 
erythrostasis { Rg . 3D).
D iu u stion
*
The measurement of CRH -IR  in the postm ortem  hypothalam i 
has been performed previously by several groups, w hich showed 
reliable changes of hypothalam ic CRH  expression in several 
hum an diseases such as depression |25|. multiple sclerosis |26|, 
hypertension 123,27), and alcoholic disease (20). Moreover.
Fig. 2 Increased VP-immunoreac tlvity In CRH neurons of CHf patients 
A: Fragment of the hypothalamic PVN of the 04-year old control and 62 
year old CHF patients (B). Immunohistochemlcal double staining with 
rabbit anti-CRH and mouse anti-VP antibodies visualised with fluorescent 
CyJ- or flTC-con|ugated secondary antibodies, respectively A/rows Indi­
cate parvoceilular CRM neurons containing VWmmuncKeactivlry Single- 
labeled CRH-posltive cells ace Indicated by arrowheads. Sc ale bar- 100 pm 
The images are maximal projection Z-stacks ol seven (in A) and eight (in 8 
confocal sections separated by 1 pm.
ACTH-IR  has been also im m unohistochem ically studied in the 
postm ortem  hypothalam us and hippocam pal formation in tem­
poral lobe epilepsy patients |28|. In the present study, com pris­
ing by the cases w ith  relatively sim ilar postm ortem  period in 
control and CHF group, we observed a profound activation of 
CRH  and ACTH expression in hum an patients afflicted w ith CHF. 
These facts are in line w ith  the results from animal models of 
CHF. show ing  that in rats w ith ischem ia-induced CHF the meta­
bolic |29| and neuronal 130) PVN activity was increased. M ore 
specifically. CRH expression in the PVN w as significantly elevated
Control CHF
2 (Continued) C  Proportion of CRH-positive neurons Immunoposi- 
Ilvc lot VP it strongly Increased in CHF patients. Group mean values ol the 
parameters are calculated Irom Individual mean values. ’p<0.05 (t-teit).
in CHF rats compared w ith  sham -operated anim als and CRH 
protein expression in hypothalam us w as 1.9-fold higher in CHF 
than sham  rats as indicated by im m unoh istochem istry and 
W estern blot analysis | !8|. The increase in num ber o f CRH  neu­
rons in the PVN was well correlated w ith  the elevation of plasma 
ACTH 119). All these observations are in agreement w ith  our 
results in hum an patients w ith  demonstrated elevation o f CRH 
exp iession and increased num bers of CRH cells co-expressing 
VP. w hich potentiates effects of CRH  on ACTH release [3 11. Fur­
thermore. lesults of the present study revealed not on ly  a sig ­
nificant increase in the density  o f CRH  neurons, but a lso an 
enhanced intensity of the staining in the PVN of CHF patients. 
These observations can se ive  as evidence for a drastic increase 
in CRH  synthesis: according to recent reports a two-fold increase 
in CRH -IR  cell num ber in the PVN o f hypertensive patients cor­
responded to a five-fold elevation of CRH  m R N A  levels (23 ,271. 
However, im m unohistochem ical technique applied to our study 
does not allow  us to definitively conclude that basal CRH release 
into the portal blood is increased in CHF patients. Therefore, fur­
ther m easurements o f CRH m R N A  levels in the hypothalam us 
and CRH  receptor type 1 m R N A  levels in the p ituitary of CHF 
patients w ill be required.
The upregulation of CRH  and V P  expi ession in CRH neurons and 
ACTH expression in the pituitary observed in our study pre­
dicted the elevation of cortisol in the blood. However, the level of 
cortisol in our CHF patients did not differ from the control group, 
and no rise of cortisol w as found in patients w ith  severe form s of 
O IF . These results are consistent w ith  previous clinical data 
show ing sim ilar plasma cortisol concentrations in CHF patients 
and healthy subjects |9| and the absence of correlation o f corti­
sol levels w ith the hem odynam ic parameters [I0|. In contrast, 
several groups reported a significant elevation o f cortisol in CHF 
patients compared to controls and a progressive increase o f its 
concentrations com m ensurate w ith  the functional class o f CHF 
113 .14|. However, profound dystrophic changes in corticocytes 
o f the zona fasculata. detected in our histological study of adre­
nal cortex, support recent convincing data dem onstrating either 
a norm al range of cortisol concentrations in CHF patients 115| or 
even decreased levels of cortisol in som e of CHF patients 112|. 
Furthermore our clinical and m orphological results are in the 
line w ith the reported decline o f cortisol responses to physical
Fie- J Pathomorphological changes in the adrenal cortex. A: The 
structure of the adrenal cortex of the 65-year old control and 62-year 
old CHI patients IB -О). В  discomplexation ol гопа glomerulosa: 
drastic thinning, plethora and dlapedesis in гопа fasciculate (Indicated 
by asterisk). C: Profound vacuolated dystrophy, pyknotic changes in 
corticocytes ol гопа fasciculata. D  Frythrostasls. dc-lipidatlon (big 
asterisk: “normal“ neighbouring tissue indicated by plus), pyknotlc 
changes In corticocytes (arrows) of гопа fasciculata. Staining with 
hematoxyfirveosin. Scale bars* 100pm (А. В. C). 50pm (0)
exercises in CHF patients 1111. The lack of m orphological evi 
dence for adrenal cortex hyperstim ulation in CHF patients, as 
well as a norm al basal corliso l levels coincided w ith  increased 
ACTH-content in the p itu itary may suggest several possibilities, 
such as the block o f ACTH  release from pituitary, decrease of 
sensitivity of adrenal cortex to ACTH, or interception of ACTH 
action w ith  other modulators. To dissect these possible m echa­
nisms, further studies of ACTH receptor expression in the 
adrenals as well as low -dose ACTH stim ulation test in CHF 
patients w ill be very informative.
The discrepancy between the CRH production and plasm agluco- 
corticoid levels has been observed in several hum an pathologies 
and som e experimental models. For example, the elevation of 
CRH  production w ithout reported increase in plasma cortisol
levels has been show n  in alcoholics |20,32) and patients w ith 
multiple sclerosis |26.33|. In opposite, the elevated cortisol lev­
els coincided w ith  the unchanged hypothalam ic C RH  expression 
in patients w ith  A lzheim er disease |34.35|. In anim al models 
the discrepancy between CRH. ACTH. and corticosterone 
responses has been earliei observed in rats w ith  chronic inflam ­
mation |36|. In  these rats subjected to repeated injections of 
bacterial endotoxin lypopolysaccharide a prom inent elevation o f 
basal CRH expression and a trend for elevation o f ACTH  expres­
sion coincided w ith  unchanged ACTH and corticosterone plasma 
levels |6|. The dysregulation between the central and peripheral 
com ponents of the HPA axis is a very important question, which 
w ill be addressed in our further studies w ith  em ploym ent of in 
situ hybridisation technique for evaluation o f CRH  and ACTH 
receptors m R N A  levels and performance o f functional tests, such 
as very low -doses ACTH  stim ulation |36| and dexamethasone 
suppression tests |37| w ith  subsequent com parison o f total and 
free fractions of plasm a cortisol 138| in CHF patients,
In conclusion, our study dem onstrates that CHF patients exhibit 
the activation o f hypothalam ic and p itu itary levels of the HPA 
axis but a failure o f  adrenal response and subsequent increase of 
system ic cortisol levels is noted. The unchanged plasma cortisol 
as well as severe m orphological im pairm ents of the adrenal cor­
tex suggests that a prim ary adrenal locus is a principal site o f the 
HPA axis dysregulation in CHF patients. The alteration of the 
adrenal cortex may lead to a m ild  (relative) deficiency o f  gluco­
corticoid production, w hich via feed-back signalling m ay lead to 
the upregulation o f  hypothalam ic CRH expression in CHF 
patients.
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